BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16403056)

  • 1. Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach.
    Gasparini M; Galimberti P; Regoli F; Ceriotti C; Bonadies M
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1279-83. PubMed ID: 16403056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety.
    Gras D; Böcker D; Lunati M; Wellens HJ; Calvert M; Freemantle N; Gervais R; Kappenberger L; Tavazzi L; Erdmann E; Cleland JG; Daubert JC;
    Europace; 2007 Jul; 9(7):516-22. PubMed ID: 17540662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.
    Duray GZ; Israel CW; Pajitnev D; Hohnloser SH
    Europace; 2008 Jan; 10(1):48-52. PubMed ID: 18077483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of left ventricular lead location on outcomes in the COMPANION study.
    Saxon LA; Olshansky B; Volosin K; Steinberg JS; Lee BK; Tomassoni G; Guarnieri T; Rao A; Yong P; Galle E; Leigh J; Ecklund F; Bristow MR
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):764-8. PubMed ID: 19298563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after implantation of cardiac resynchronization/defibrillation systems in patients with congestive heart failure and left bundle-branch block.
    Pfau G; Schilling T; Kozian A; Lux A; Götte A; Huth C; Hachenberg T
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):30-6. PubMed ID: 19800818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
    J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of cardiac resynchronization therapy-defibrillator for treating patients with chronic heart disease].
    Hua W; Zhang S; Wang FZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Dec; 35(12):1096-8. PubMed ID: 18341807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemodynamic effects of right and left ventricular lead positions during the implantation of cardiac resynchronization therapy defibrillators.
    Stockinger J; Staier K; Schiebeling-Römer J; Keyl C
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1537-43. PubMed ID: 21797906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term retention of cardiac resynchronization therapy.
    Knight BP; Desai A; Coman J; Faddis M; Yong P
    J Am Coll Cardiol; 2004 Jul; 44(1):72-7. PubMed ID: 15234410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block.
    Shimano M; Tsuji Y; Yoshida Y; Inden Y; Tsuboi N; Itoh T; Suzuki H; Muramatsu T; Okada T; Harata S; Yamada T; Hirayama H; Nattel S; Murohara T
    Europace; 2007 Oct; 9(10):869-74. PubMed ID: 17557768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.